You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival
|
|---|---|
| Published in |
Genome Medicine, June 2014
|
| DOI | 10.1186/gm567 |
| Pubmed ID | |
| Authors |
Shahzia Anjum, Evangelia-Ourania Fourkala, Michal Zikan, Andrew Wong, Aleksandra Gentry-Maharaj, Allison Jones, Rebecca Hardy, David Cibula, Diana Kuh, Ian J Jacobs, Andrew E Teschendorff, Usha Menon, Martin Widschwendter |
| Abstract |
BRCA1 mutation carriers have an 85% risk of developing breast cancer but the risk of developing non-hereditary breast cancer is difficult to assess. Our objective is to test whether a DNA methylation (DNAme) signature derived from BRCA1 mutation carriers is able to predict non-hereditary breast cancer. |
X Demographics
The data shown below were collected from the profiles of 73 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 20 | 27% |
| United States | 16 | 22% |
| France | 3 | 4% |
| Switzerland | 1 | 1% |
| Venezuela, Bolivarian Republic of | 1 | 1% |
| Australia | 1 | 1% |
| Brazil | 1 | 1% |
| Canada | 1 | 1% |
| Spain | 1 | 1% |
| Other | 1 | 1% |
| Unknown | 27 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 44 | 60% |
| Scientists | 18 | 25% |
| Practitioners (doctors, other healthcare professionals) | 7 | 10% |
| Science communicators (journalists, bloggers, editors) | 4 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| Denmark | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 121 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 23 | 18% |
| Researcher | 21 | 17% |
| Student > Master | 14 | 11% |
| Student > Bachelor | 12 | 9% |
| Other | 11 | 9% |
| Other | 32 | 25% |
| Unknown | 14 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 37 | 29% |
| Medicine and Dentistry | 33 | 26% |
| Biochemistry, Genetics and Molecular Biology | 26 | 20% |
| Computer Science | 3 | 2% |
| Nursing and Health Professions | 2 | 2% |
| Other | 8 | 6% |
| Unknown | 18 | 14% |
Attention Score in Context
This research output has an Altmetric Attention Score of 159. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 December 2020.
All research outputs
#258,316
of 25,494,370 outputs
Outputs from Genome Medicine
#37
of 1,592 outputs
Outputs of similar age
#2,022
of 242,687 outputs
Outputs of similar age from Genome Medicine
#2
of 26 outputs
Altmetric has tracked 25,494,370 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,592 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,687 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.